MedTrace Logo

Virtual Reality Intradialysis: Last vs. First Part of the Session

NCT04046042 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-06-14

No results posted yet for this study

Summary

The main objective of this investigation is to assess if an intradialysis virtual reality exercise program during the last two hours of the hemodialysis session results in greater hemodynamic stability than exercise performed during the first two hours of the hemodialysis session.

The secondary aims are to assess the impact of intradialysis virtual reality exercise during the last two hours of the hemodialysis session on dialysis efficacy, postdialysis molecules rebound, adherence to exercise, functional capacity, physical activity level, health-related quality of life, cognitive function, morbidity, frailty and dependency. We will also analyze the reliability of muscle strength assessment of lower limb muscles with a handheld dynamometer during hemodialysis.

Conditions

  • End Stage Renal Disease on Dialysis
  • Hemodialysis Complication

Interventions

OTHER

Conventional exercise

Virtual reality exercise performed during the first two hours of the hemodialysis session

OTHER

Exercise during the last two hours of the hemodialysis session

Virtual reality exercise performed during the last two hours of the hemodialysis session

Sponsors & Collaborators

  • Hospital de Manises

    collaborator OTHER

  • Universitat Politècnica de Valéncia

    collaborator UNKNOWN

  • Cardenal Herrera University

    lead OTHER

Principal Investigators

  • Eva Segura-Ortí, PhD · Universidad CEU Cardenal Herrera, UCH CEU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-02
Primary Completion
2024-08-29
Completion
2024-08-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04046042 on ClinicalTrials.gov